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MS is a multiplex cardio-metabolic disorder which clusters together in the same individual 
















simpler and more operational
JIS 2009
3 or more of the following 5 criteria
1) ↑TG ≥ 150 mg/dl or treatment
2) ↓HDL-C < 40 mg/dl  ♂
< 50 mg/dl ♀ or treatment
3) ↑ SBP ≥ 130 mmHg
DBP ≥ 85 mmHg or treatment
4) ↑FPG ≥ 100 mg/dl or treatment












Age, gender, family history, smoking
Traditional risk assessment tools
www.crp-sante.lu












Age, gender, family history, smoking
Traditional risk assessment tools
• MS alone can not improve prediction of global CVD risk
• Traditional tools do not capture additional risk (obesity)
Global Cardio-Metabolic Risk concept
The “building blocks” of global cardiometabolic risk, with adaptation from Desprès et al 2008
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Luxembourgers   56.3%
Foreigners      43.7%
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Highest mortality among 
the Western countries
European detailed mortality database (DMDB)



























No data for Luxembourg













• Investigate the epidemiological profile of MS in the general 
resident population of Luxembourg
Inductive exploratory approach
• Identify the potential socio-economic and behavioral 
determinants of MS
“Group at risk”
« Evidence-based interventions »
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Observation of Cardiovascular Risk Factors
in Luxembourg
• 1st nationwide cross-sectional survey (November 2007-
January 2009)
• Population of residents (18-69 years) of Luxembourg



























The distribution of selected subjects in each stratum is proportional to their distribution in the source population
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Comparison of participants to source population according to age groups
P<0.0001 
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• Demographic indicators (profession, nationality)
• Morbidity indicators (prescribed medications, 
hospital admission and medical measures)
Sample representativeness (4)
To assess whether the health status affected the response rate
Comparison between participants and non-participants
National medical administrative 
database
Allows generalizing the findings for the population
Investigated clinical profile (hospital admission and 
cardiovascular health-related medical measures) was 
comparable in both groups (participants vs non-participants) 
Sample representativeness (4)
*Alkerwi et  al. BMC Medical Research Methodology 2010, 10:80
Conclusion*





↑ TG ≥ 150 mg/dl
↑ SBP ≥ 130 mmHg
↑ DBP ≥ 85 mmHg
≥ 88 cm≥ 102 cm
<50 mg/dl 
or treatment






































































































































Metabolic syndrome – Logistic regression
Socio-economic factors
Reference category: married, university level of education, employed, working women, easy subjective economical status, above risk of poverty threshold
Variable
Epidemiological profile (5)
Age and gender adjusted odd ratio
Yes
Reference category: non-smokers, less than 10 cigarettes/day, physically active
Metabolic syndrome – Logistic regression 
Lifestyle factors
Epidemiological profile (6)
Variable Age and gender adjusted odd ratio
Reference category:  no family history of (hypertension, diabetes, myocardial infarction, CVA
Metabolic syndrome – Logistic regression 
Family history
Epidemiological profile (7)
Age and gender adjusted odd ratioVariable
Reference categories are those who respect the WHO recommendations, 2003
9 Decembre 2010






Age and gender adjusted odd ratio
Metabolic syndrome – Logistic regression 
Final multivariate model
Epidemiological profile (9)









• The MS is an important health problem in Luxembourg (24.7%)
• MS increases remarkably with age in both genders
• Significant gender-specific differences
• Low education level, physical inactivity, inadequate protein diet 
and family history of diabetes and hypertension were the most 
important determinants of the MS
• Lifestyle-oriented intervention might be the promising approach 
for the primary prevention of MS
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• First reliable source of information for Luxembourg
• Provides scientific evidence for public health decision-makers 
• Increases Luxembourg visibility at international level
• Model to reproduce the study in the neighboring regions
• Reinforcement of international collaboration
• Generates new hypotheses for future research
Added-values of the study
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